Magnesium malate
Magnesium malate is an orally active organic acid-chelated magnesium complex. Magnesium malate promotes the release of prostaglandin E2 (PGE2) from macrophages, synergistically stimulates the synthesis/release of calcitonin gene-related peptide (CGRP) from dorsal root ganglion neurons, and upregulates the osteogenic transcription factor RUNX2 in osteoblasts via the Mg2+-PGE2-CGRP axis, thereby promoting osteoblast proliferation. Magnesium malate can be incorporated into calcium phosphate bone cement as a modifying component to improve compressive strength, shorten setting time and enhance disintegration resistance. Magnesium malate increases serum magnesium levels. Magnesium malate can be used in studies related to bone defects and magnesium deficiency.
For research use only. We do not sell to patients.
- CAS No.: 869-06-7
- Formula: C4H6MgO5
- Molecular Weight:158.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
RUNX2 |
In Vitro
Magnesium malate (5 wt%) incorporated into calcium phosphate bone cement can shorten the final setting time to less than 40 minutes, improve disintegration resistance, and increase compressive strength to 6.18 MPa. It gradually degrades in vitro, continuously releasing magnesium ions, reaching 318.49 mg/L at 35 days[1].
Magnesium malate (5 wt%)-modified calcium phosphate bone cement extracts are biocompatible with MC3T3-E1 pre-osteoblasts, supporting cell adhesion, viability, and proliferation that is significantly greater than control medium after 3 days of culture[1].
Magnesium malate can prolong axonal growth in primary dorsal root ganglion (DRG) neurons and synergistically increase intracellular and secretory CGRP levels in neurons with PGE2; it can upregulate RUNX2 expression in MC3T3-E1 osteoblast progenitor cells, expand ALP-positive areas, and increase calcium nodule formation[1].
Magnesium malate, either as a standalone extract or incorporated into calcium phosphate bone cement, significantly enhances PGE2 release from LPS-induced RAW264.7 macrophages compared to control, CPC, and MgCl2 groups[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
Magnesium malate (45-405 mg/70 kg elemental magnesium; p.o.; single dose or two doses 12 hours apart) significantly increases serum magnesium levels at all tested doses, but does not alter brain magnesium levels at any dose, causes a small decrease in muscle magnesium only at the lowest dose, and shows no difference in efficacy between single high-dose and divided high-dose regimens[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (adult, gender not specified)[2]
-
Dosage:45 mg/70 kg elemental magnesium; 135 mg/70 kg elemental magnesium; 405 mg/70 kg elemental magnesium; 202.5 mg/70 kg elemental magnesium (total 405 mg/70 kg elemental magnesium)
-
Administration:p.o.; single dose
p.o.; two doses 12 hours apart -
Result:Exhibited equivalent brain magnesium concentrations without inter-dose or control-significant disparities.
Recorded reduced muscle magnesium at 45 mg/70 kg (12.5 mg/g tissue, significant vs control), while 135 and 405 mg/70 kg doses (13.5, 12.7 mg/g tissue) matched control levels.
Detected uniformly elevated serum magnesium, all statistically higher than control values.
Measured comparable brain magnesium (6.4 mg/g protein) for split 202.5 mg/70 kg dose relative to control and single high-dose groups.
Captured identical muscle magnesium (13.5 mg/g tissue) for divided dosing versus control and single high-dose cohorts.
Observed elevated serum magnesium (2.8 mg/dL) under split dosing, with no divergence from single high-dose outcomes.
Chemical Information
-
CAS No. 869-06-7
-
Molecular Weight 158.38
-
Formula C4H6MgO5
-
SMILES
O=C(CC(C(O[Mg])=O)O)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Nuclear Protein Extraction (High-Salt/Hypotonic Fractionation)
The high-salt/hypotonic fractionation method for nuclear protein extraction is based on the differential solubility of cellular components. Cytoplasmic proteins are extracted first using a hypotonic buffer that causes cell swelling and membrane rupture, followed by centrifugation to separate the cytoplasmic supernatant from the nuclear pellet. The nuclear pellet is then subjected to high-salt extraction (e. g. , 0. 4 M (NH4)2SO4 or 1 M NaCl) to solubilize tightly bound nuclear matrix proteins, including transcription factors, histones, and structural proteins associated with chromatin and the nuclear scaffold. This approach allows for the isolation of both soluble cytoplasmic proteins and salt-resistant nuclear proteins while minimizing cross-contamination.
-
Primary Dorsal Root Ganglion Sensory Neuron Culture
Primary dorsal root ganglion sensory neuron culture isolates DRG neuronal somata from rodent or human ganglia, dissociates tissue enzymatically and mechanically, and maintains post-mitotic sensory neurons in vitro for readouts such as neurite outgrowth, immunocytochemical marker expression, calcium imaging, electrophysiology, RNA/protein analysis, or neuropeptide release assays. The method reflects peripheral sensory neuron biology because DRG neurons are primary sensory neurons whose cell bodies reside in dorsal root ganglia and whose cultured dissociated cells can retain neuronal morphology, sensory-neuron marker expression, and stimulus-responsive properties depending on the downstream assay.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
[1]. Xu H, et al. Magnesium malate-modified calcium phosphate bone cement promotes the repair of vertebral bone defects in minipigs via regulating CGRP. Journal of nanobiotechnology. 2024 Jun 25;22(1):368. [Content Brief]
[2]. Ates M, et al. Dose-Dependent Absorption Profile of Different Magnesium Compounds. Biological trace element research. 2019 Dec;192(2):244-251. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)